CDH1 and benign prostatic hyperplasia: This study demonstrated that E-cadherin downregulation with enhanced prostatic inflammation further promoted BPH-like phenotypic changes in the prostate and bladder overactivity, which is one of the hallmark manifestations of male LUTS associated with BPH, in addition to voiding dysfunction, to which the aging process seems to be an important contributing factor.